![](/img/cover-not-exists.png)
1164PPatterns of progression under antiPD1/PDL1 in advanced NSCLC patients allow discriminating pseudo-progression from real progression
Caramella, C., Tazdait, M., Mezquita, L., Lahmar, J., Ferrara, R., Marabelle, A., Balleyguier, C., Planchard, D., Gazzah, A., Soria, J-C., Besse, B.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx376.029
Date:
September, 2017
File:
PDF, 45 KB
english, 2017